aubagio
sanofi winthrop industrie - teriflunomidă - scleroză multiplă - imunosupresoare selective - aubagio is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).
aubagio 14 mg comprimate filmate
sanofi-aventis groupe - teriflunomidum - comprimate filmate - 14 mg
aubagio 14 mg comprimate filmate
sanofi winthrop industrie - teriflunomidum - comprimate filmate - 14 mg
aubagio
opella healthcare international sas - franta - teriflunomidum - compr. film. - 14mg - imunosupresoare imunosupresoare selective
aubagio
opella healthcare international sas - franta - teriflunomidum - compr. film. - 7mg - imunosupresoare imunosupresoare selective
termostat-incubator de precizie, tip tc 25
sc caloris group sa -
termostat-incubator de precizie, tip tc 50
sc caloris group sa -
termostat-incubator de precizie, tip tc 100
sc caloris group sa -
termostat-incubator de precizie, tip tc 200
sc caloris group sa -
termostat-incubator de precizie, tip tc 400
sc caloris group sa -